twenty-six essential hypertensive patients were entered into a protocol to assess the blood pressure and renal effects of the dihydropyridine calcium antagonist nifedipine ( 30-120 mg/day given in divided doses ) administered for 4 weeks .
C2945601
dihydropyridine calcium
C0028066
nifedipine